Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson's disease

被引:51
|
作者
Blesa, Javier [1 ,2 ]
Juri, Carlos [1 ,3 ]
Garcia-Cabezas, Miguel A. [4 ,5 ]
Adanez, Rebeca [1 ,2 ]
Sanchez-Gonzalez, Miguel A. [4 ,5 ]
Cavada, Carmen [4 ,5 ]
Obeso, Jose A. [1 ,2 ]
机构
[1] Clin Univ Navarra, Ctr Invest Med Aplicada, Dept Neurol & Neurociugia, Lab Trastornos Movimiento,Neurociencias, Pamplona, Spain
[2] Inst Carlos III, Minist Ciencia & Innovat, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain
[3] Pontificia Univ Catolica Chile, Dept Neurol, Santiago, Chile
[4] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain
[5] Inst Invest Sanitaria IdiPAZ, Madrid, Spain
来源
FRONTIERS IN SYSTEMS NEUROSCIENCE | 2011年 / 5卷
关键词
MPTP; Parkinson's disease; PET; dopaminergic; F-18-DOPA; compensatory mechanisms;
D O I
10.3389/fnsys.2011.00092
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The onset of Parkinson's disease (PD) is characterized by focal motor features in one body part, which are usually correlated with greater dopaminergic depletion in the contralateral posterior putamen. The role of dopamine (DA) hemispheric differences in the onset and progression of motor symptoms of PD, however, remains undefined. Previous studies have demonstrated that unilateral manipulations of one nigrostriatal system affect contralateral DA turnover, indicating a functional and compensatory inter-dependence of the two nigrostriatal systems. In preliminary data obtained by our group from asymmetric PD patients, a higher asymmetry index as measured by 6-[F-18]fluoro-L-dopa (F-18-DOPA) positron emission tomography (PET) was associated with a higher threshold (i.e., greater dopaminergic loss) for the onset of motor symptoms in the less-affected side. To further elucidate the underlying basis for this, we carried out a complementary study in monkeys using PET to assess and correlate the degree of dopaminergic striatal depletion with motor activity. Control and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated monkeys with symmetrical lesions were characterized behaviorally and with F-18-DOPA PET. In parallel, an acute lesion was inflicted in the nigrostriatal projection unilaterally in one monkey, generating a 30% dopaminergic depletion in the ipsilateral striatum, which was not associated with any noticeable parkinsonian feature or deficit. The monkey remained asymptomatic for several months. Subsequently, this monkey received systemic MPTP, following which motor behavior and PET were repeatedly evaluated during progression of parkinsonian signs. The brains of all monkeys were processed using immunohistochemical methods. Our results suggest that the onset of motor signs is related to and influenced by the dopaminergic status of the less-affected, contralateral striatum. Although this work is still preliminary, the study agrees with our general hypothesis of hemispheric inter-dependence in the compensation of striatal DA deficit in PD
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease
    Kim, Han-Kyeol
    Kim, Tae Won
    Baek, Min Seok
    Kim, Eung Yeop
    Sung, Young Hee
    Lee, Jae Hoon
    Ryu, Young Hoon
    Ahn, Sung Jun
    Yoo, Han Soo
    Lyoo, Chul Hyoung
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (06) : 1639 - 1647
  • [42] Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease
    Ouchi, Y
    Kanno, T
    Okada, H
    Yoshikawa, E
    Futatsubashi, M
    Nobezawa, S
    Torizuka, T
    Tanaka, K
    BRAIN, 2001, 124 : 784 - 792
  • [43] Monitoring therapeutic effects in Parkinson's disease by serial imaging of the nigrostriatal dopaminergic pathway
    Booij, Jan
    Berendse, Henk W.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 310 (1-2) : 40 - 43
  • [44] Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson’s disease
    G Drui
    S Carnicella
    C Carcenac
    M Favier
    A Bertrand
    S Boulet
    M Savasta
    Molecular Psychiatry, 2014, 19 : 358 - 367
  • [45] Analysis of volatile organic compounds in rats with dopaminergic lesion: Possible application for early detection of Parkinson's disease
    Khatib, S.
    Finberg, J. P. M.
    Artoul, F.
    Lavner, Y.
    Mahmood, S.
    Tisch, U.
    Haick, H.
    Aluf, Y.
    Vaya, J.
    NEUROCHEMISTRY INTERNATIONAL, 2014, 76 : 82 - 90
  • [46] Diplopia in Parkinson's disease, a possible role of dopaminergic treatment
    Belli, E.
    Del Prete, E.
    Frosini, D.
    Bonuccelli, U.
    Ceravolo, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 638 - 638
  • [47] Parkinson's disease and pain: Modulation of nociceptive circuitry in a rat model of nigrostriatal lesion
    Domenici, Roberta A.
    Campos, Aria Carolina P.
    Maciel, Soraya T.
    Berzuino, Miria B.
    Hernandes, Marina S.
    Fonoff, Erich T.
    Pagano, Rosana L.
    EXPERIMENTAL NEUROLOGY, 2019, 315 : 72 - 81
  • [48] Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons
    Iwakura, Y
    Piao, YS
    Mizuno, M
    Takei, N
    Kakita, A
    Takahashi, H
    Nawa, H
    JOURNAL OF NEUROCHEMISTRY, 2005, 93 (04) : 974 - 983
  • [49] Urinary 8-OHdG Elevations in a Partial Lesion Rat Model of Parkinson's Disease Correlate With Behavioral Symptoms and Nigrostriatal Dopaminergic Depletion
    Kikuchi, Yoichiro
    Yasuhara, Takao
    Agari, Takashi
    Kondo, Akihiko
    Kuramoto, Satoshi
    Kameda, Masahiro
    Kadota, Tomohito
    Baba, Tanefumi
    Tajiri, Naoki
    Wang, Feifei
    Tayra, Judith T.
    Liang, Hanbai
    Miyoshi, Yasuyuki
    Borlongan, Cesario V.
    Date, Isao
    JOURNAL OF CELLULAR PHYSIOLOGY, 2011, 226 (05) : 1390 - 1398
  • [50] A NEW APPROACH TO ASSESSMENT THE DEGRADATION OF THE NIGROSTRIATAL DOPAMINERGIC SYSTEM IN THE EXPERIMENTAL MODEL OF PARKINSON'S DISEASE
    Safandeev, V. V.
    Ugrumov, M. V.
    ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA, 2019, 69 (03) : 382 - 392